Supprelin La
Puberty, Precocious, Prostatic Neoplasms
Treatment
1 Active Study for Supprelin La
Treatment for
Puberty, Precocious
What is Supprelin La
Histrelin
The Generic name of this drug
Treatment Summary
Histrelin is a medication used to reduce the production of hormones in the body. The drug is given as an implant and works by temporarily blocking the body's hormone production, then gradually decreasing it over time. Histrelin is used to treat central precocious puberty in children and advanced prostate cancer in adults.
Vantas
is the brand name
Supprelin La Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Vantas
Histrelin
2004
3
Effectiveness
How Supprelin La Affects Patients
Histrelin is a medication used to reduce the levels of hormones that trigger puberty. It is taken either as an implant or injection, but not orally. After treatment, hormone levels will decrease to prepubertal levels. Laboratory tests may be recommended to monitor hormone levels in patients. Side effects may include psychiatric events, convulsions, pseudotumor cerebri, spinal cord compression, urinary tract obstruction, and an increased risk of hyperglycemia/diabetes and cardiovascular disease.
How Supprelin La works in the body
Histrelin is a hormone drug that helps regulate sexual maturity and reproduction. When administered as an implant, it works by initially activating the hormones that produce sex steroids in the body. Then, over time, it reduces the hormone levels and desensitizes the hormones in the pituitary gland. This makes it effective for treating central precocious puberty in children, as it lowers their height potential. In adult males, it reduces testosterone production, which slows the growth of prostate cancer cells.
When to interrupt dosage
The advocated measure of Supprelin La is reliant upon the specified condition. The quantity of dosage varies, contingent upon the technique of delivery (e.g. Implant; Kit or Implant; Kit - Subcutaneous) featured in the table below.
Condition
Dosage
Administration
Puberty, Precocious
50.0 mg,
, Implant, Subcutaneous, Implant - Subcutaneous, Implant; Kit, Implant; Kit - Subcutaneous
Prostatic Neoplasms
50.0 mg,
, Implant, Subcutaneous, Implant - Subcutaneous, Implant; Kit, Implant; Kit - Subcutaneous
Warnings
Supprelin La Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Supprelin La.
Common Supprelin La Drug Interactions
Drug Name
Risk Level
Description
Capromab pendetide
Major
Histrelin may decrease effectiveness of Capromab pendetide as a diagnostic agent.
Corifollitropin alfa
Major
The therapeutic efficacy of Corifollitropin alfa can be increased when used in combination with Histrelin.
Hydroxyzine
Major
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Hydroxyzine.
Mobocertinib
Major
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Mobocertinib.
Ziprasidone
Major
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Ziprasidone.
Supprelin La Toxicity & Overdose Risk
Animal studies have shown that taking up to 200mcg/kg (rats and rabbits) or 2000mcg/kg (mice) of histrelin acetate is safe and does not cause systemic toxicity. This amount is much higher than the recommended human dose of 10mcg/kg/day. Clinical trials of histrelin products have not reported any overdose cases. Histrelin products are usually administered using implants that release a constant dose, so accidental or intentional overdose is unlikely.
Supprelin La Novel Uses: Which Conditions Have a Clinical Trial Featuring Supprelin La?
Currently, four trials are being conducted to evaluate the potential of Supprelin La to alleviate Advanced Prostate Cancer.
Condition
Clinical Trials
Trial Phases
Prostatic Neoplasms
0 Actively Recruiting
Puberty, Precocious
1 Actively Recruiting
Phase 3
Supprelin La Reviews: What are patients saying about Supprelin La?
5
Patient Review
2/15/2009
Supprelin La for Puberty at an Earlier Age than would be expected
5
Patient Review
3/24/2009
Supprelin La for Puberty at an Earlier Age than would be expected
5
Patient Review
7/10/2018
Supprelin La for Puberty at an Earlier Age than would be expected
5
Patient Review
2/15/2009
Supprelin La for Puberty at an Earlier Age than would be expected
5
Patient Review
3/24/2009
Supprelin La for Puberty at an Earlier Age than would be expected
5
Patient Review
7/10/2018
Supprelin La for Puberty at an Earlier Age than would be expected
4.7
Patient Review
10/1/2008
Supprelin La for Puberty at an Earlier Age than would be expected
4.7
Patient Review
10/1/2008
Supprelin La for Puberty at an Earlier Age than would be expected
4.3
Patient Review
2/17/2015
Supprelin La for Puberty at an Earlier Age than would be expected
4.3
Patient Review
2/17/2015
Supprelin La for Puberty at an Earlier Age than would be expected
4
Patient Review
11/20/2012
Supprelin La for Puberty at an Earlier Age than would be expected
4
Patient Review
3/14/2012
Supprelin La for Puberty at an Earlier Age than would be expected
4
Patient Review
11/20/2012
Supprelin La for Puberty at an Earlier Age than would be expected
4
Patient Review
3/14/2012
Supprelin La for Puberty at an Earlier Age than would be expected
3.7
Patient Review
7/18/2012
Supprelin La for Puberty at an Earlier Age than would be expected
3.7
Patient Review
7/18/2012
Supprelin La for Puberty at an Earlier Age than would be expected
2.7
Patient Review
2/10/2012
Supprelin La for Puberty at an Earlier Age than would be expected
2.7
Patient Review
2/10/2012
Supprelin La for Puberty at an Earlier Age than would be expected
1.3
Patient Review
2/18/2014
Supprelin La for Puberty at an Earlier Age than would be expected
1.3
Patient Review
2/18/2014
Supprelin La for Puberty at an Earlier Age than would be expected
Patient Q&A Section about supprelin la
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is Supprelin LA used for?
"Supprelin LA is an implant used to treat central precocious puberty (CPP) in children. CPP is a condition that causes children to enter puberty too soon, resulting in faster than normal bone growth and development of sexual characteristics."
Answered by AI
How much is supprelin implant?
"Histrelin acetate is a drug that is used to treat early puberty. It is an implant that is put into the body to deliver the drug over a long period of time. The price of the drug is $37,300."
Answered by AI
Who manufactures Supprelin LA?
", Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced that SUPPRELIN(R)-LA (histrelin acetate subcutaneous implant) 50mg has been approved by the U.S. Food and Drug Administration (FDA). SUPPRELIN(R)-LA is the first and only once-yearly subcutaneous implant for the treatment of central precocious puberty (CPP) in girls."
Answered by AI
Where is supprelin implant?
"Supprelin LA is a medication that is inserted under the skin on the inside of the upper arm to prevent further progression through puberty. The medication is slowly released into the tissues."
Answered by AI